These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38879812)

  • 1. Therapy-induced senescence is finally escapable, what is next?
    Saleh T
    Cell Cycle; 2024 Mar; 23(6):713-721. PubMed ID: 38879812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA Damage- But Not Enzalutamide-Induced Senescence in Prostate Cancer Promotes Senolytic Bcl-xL Inhibitor Sensitivity.
    Malaquin N; Vancayseele A; Gilbert S; Antenor-Habazac L; Olivier MA; Ait Ali Brahem Z; Saad F; Delouya G; Rodier F
    Cells; 2020 Jul; 9(7):. PubMed ID: 32630281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can 3D bioprinting solve the mystery of senescence in cancer therapy?
    Shboul SA; DeLuca VJ; Dweiri YA; Saleh T
    Ageing Res Rev; 2022 Nov; 81():101732. PubMed ID: 36100069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting tumor cell senescence and polyploidy as potential therapeutic strategies.
    Saleh T; Carpenter VJ; Bloukh S; Gewirtz DA
    Semin Cancer Biol; 2022 Jun; 81():37-47. PubMed ID: 33358748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen-deprivation induced senescence in prostate cancer cells is permissive for the development of castration-resistance but susceptible to senolytic therapy.
    Carpenter V; Saleh T; Min Lee S; Murray G; Reed J; Souers A; Faber AC; Harada H; Gewirtz DA
    Biochem Pharmacol; 2021 Nov; 193():114765. PubMed ID: 34536356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamine promotes escape from therapy-induced senescence in tumor cells.
    Pacifico F; Badolati N; Mellone S; Stornaiuolo M; Leonardi A; Crescenzi E
    Aging (Albany NY); 2021 Sep; 13(17):20962-20991. PubMed ID: 34492636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detecting Markers of Therapy-Induced Senescence in Cancer Cells.
    Fan DN; Schmitt CA
    Methods Mol Biol; 2017; 1534():41-52. PubMed ID: 27812866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy-Induced Senescence: Novel Approaches for Markers Identification.
    Pacifico F; Magni F; Leonardi A; Crescenzi E
    Int J Mol Sci; 2024 Aug; 25(15):. PubMed ID: 39126015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy-Induced Senescence: An "Old" Friend Becomes the Enemy.
    Saleh T; Bloukh S; Carpenter VJ; Alwohoush E; Bakeer J; Darwish S; Azab B; Gewirtz DA
    Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32235364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular Senescence: The Sought or the Unwanted?
    Sun Y; Coppé JP; Lam EW
    Trends Mol Med; 2018 Oct; 24(10):871-885. PubMed ID: 30153969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-Two Punch Therapy for the Treatment of T-Cell Malignancies Involving p53-Dependent Cellular Senescence.
    Qing Y; Li H; Zhao Y; Hu P; Wang X; Yu X; Zhu M; Wang H; Wang Z; Guo Q; Hui H
    Oxid Med Cell Longev; 2021; 2021():5529518. PubMed ID: 34603598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer.
    Chambers CR; Ritchie S; Pereira BA; Timpson P
    Mol Oncol; 2021 Dec; 15(12):3242-3255. PubMed ID: 34137158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Jekyll and Hyde of Cellular Senescence in Cancer.
    Demirci D; Dayanc B; Mazi FA; Senturk S
    Cells; 2021 Jan; 10(2):. PubMed ID: 33494247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical antitumor efficacy of senescence-inducing chemotherapy combined with a nanoSenolytic.
    Galiana I; Lozano-Torres B; Sancho M; Alfonso M; Bernardos A; Bisbal V; Serrano M; Martínez-Máñez R; Orzáez M
    J Control Release; 2020 Jul; 323():624-634. PubMed ID: 32376460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interplay between apoptosis and cellular senescence: Bcl-2 family proteins as targets for cancer therapy.
    Basu A
    Pharmacol Ther; 2022 Feb; 230():107943. PubMed ID: 34182005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escape from senescence: molecular basis and therapeutic ramifications.
    Evangelou K; Belogiannis K; Papaspyropoulos A; Petty R; Gorgoulis VG
    J Pathol; 2023 Aug; 260(5):649-665. PubMed ID: 37550877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutritional Niches of Cancer Therapy-Induced Senescent Cells.
    Llop-Hernández À; Verdura S; Cuyàs E; Menendez JA
    Nutrients; 2022 Sep; 14(17):. PubMed ID: 36079891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular Senescence and Anti-Cancer Therapy.
    You J; Dong R; Ying M; He Q; Cao J; Yang B
    Curr Drug Targets; 2019; 20(7):705-715. PubMed ID: 30556499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the role of senescence in tumor dormancy: mechanisms and applications.
    DeLuca VJ; Saleh T
    Cancer Metastasis Rev; 2023 Mar; 42(1):19-35. PubMed ID: 36681750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-Cell Autonomous Effects of the Senescence-Associated Secretory Phenotype in Cancer Therapy.
    Saleh T; Tyutynuk-Massey L; Cudjoe EK; Idowu MO; Landry JW; Gewirtz DA
    Front Oncol; 2018; 8():164. PubMed ID: 29868482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.